TimesSquare Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $26.7M | Sell |
|
|||||
|
2024
Q1 | $36.6M | Buy |
|
|||||
|
2023
Q4 | $7.53M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $6.51M | Sell |
|
|||||
|
2022
Q3 | $7.28M | Sell |
|
|||||
|
2022
Q2 | $51M | Sell |
|
|||||
|
2022
Q1 | $91.4M | Sell |
|
|||||
|
2021
Q4 | $143M | Buy |
|
|||||
|
2021
Q3 | $155M | Sell |
|
|||||
|
2021
Q2 | $185M | Sell |
|
|||||
|
2021
Q1 | $172M | Sell |
|
|||||
|
2020
Q4 | $202M | Buy |
|
|||||
|
2020
Q3 | $139M | Sell |
|
|||||
|
2020
Q2 | $112M | Sell |
|
|||||
|
2020
Q1 | $92.6M | Sell |
|
|||||
|
2019
Q4 | $121M | Sell |
|
|||||
|
2019
Q3 | $133M | Buy |
|
|||||
|
2019
Q2 | $129M | Buy |
|
|||||
|
2019
Q1 | $125M | Sell |
|
|||||
|
2018
Q4 | $116M | Sell |
|
|||||
|
2018
Q3 | $156M | Buy |
|
|||||
|
2018
Q2 | $113M | Buy |
|
|||||
|
2018
Q1 | $91.8M | Sell |
|
|||||
|
2017
Q4 | $100M | Buy |
|
|||||
|
2017
Q3 | $35.2M | Buy |
|